Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: Mechanisms, implications, and management options

Frank Porreca, Michael H. Ossipov

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Objectives. Gastrointestinal (GI) side effects such as nausea and vomiting are common following opioid analgesia and represent a significant cause of patient discomfort and treatment dissatisfaction. This review examines the mechanisms that produce these side effects, their impact on treatment outcomes in chronic pain patients, and counteractive strategies. Results. A number of mechanisms by which opioids produce nausea and vomiting have been identified. These involve both central and peripheral sites including the vomiting center, chemoreceptor trigger zones, cerebral cortex, and the vestibular apparatus of the brain, as well as the GI tract itself. Nausea and vomiting have a negative impact on treatment efficacy and successful patient management because they limit the effective analgesic dosage that can be achieved and are frequently reported as the reason for discontinuation of opioid pain medication or missed doses. While various strategies such as antiemetic agents or opioid switching can be employed to control these side effects, neither option is ideal because they are not always effective and incur additional costs and inconvenience. Opioid-sparing analgesic agents may provide a further alternative to avoid nausea and vomiting due to their reduced reliance on mu-opioid signalling pathways to induce analgesia. Conclusions. Nausea and vomiting side effects limit the analgesic efficiency of current opioid therapies. There is a clear need for the development of improved opioid-based analgesics that mitigate these intolerable effects.

Original languageEnglish (US)
Pages (from-to)654-662
Number of pages9
JournalPain Medicine
Volume10
Issue number4
DOIs
StatePublished - 2009

Fingerprint

Chronic Pain
Nausea
Opioid Analgesics
Vomiting
Analgesics
Therapeutics
Analgesia
Labyrinth Vestibule
Area Postrema
Antiemetics
Cerebral Cortex
Gastrointestinal Tract
Costs and Cost Analysis
Pain
Brain

Keywords

  • Adverse events
  • Chronic pain
  • Gastrointestinal
  • Nausea
  • Opioids
  • Vomiting

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain : Mechanisms, implications, and management options. / Porreca, Frank; Ossipov, Michael H.

In: Pain Medicine, Vol. 10, No. 4, 2009, p. 654-662.

Research output: Contribution to journalArticle

@article{50b7d9be614d4a50950879bdbbc3b3bc,
title = "Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: Mechanisms, implications, and management options",
abstract = "Objectives. Gastrointestinal (GI) side effects such as nausea and vomiting are common following opioid analgesia and represent a significant cause of patient discomfort and treatment dissatisfaction. This review examines the mechanisms that produce these side effects, their impact on treatment outcomes in chronic pain patients, and counteractive strategies. Results. A number of mechanisms by which opioids produce nausea and vomiting have been identified. These involve both central and peripheral sites including the vomiting center, chemoreceptor trigger zones, cerebral cortex, and the vestibular apparatus of the brain, as well as the GI tract itself. Nausea and vomiting have a negative impact on treatment efficacy and successful patient management because they limit the effective analgesic dosage that can be achieved and are frequently reported as the reason for discontinuation of opioid pain medication or missed doses. While various strategies such as antiemetic agents or opioid switching can be employed to control these side effects, neither option is ideal because they are not always effective and incur additional costs and inconvenience. Opioid-sparing analgesic agents may provide a further alternative to avoid nausea and vomiting due to their reduced reliance on mu-opioid signalling pathways to induce analgesia. Conclusions. Nausea and vomiting side effects limit the analgesic efficiency of current opioid therapies. There is a clear need for the development of improved opioid-based analgesics that mitigate these intolerable effects.",
keywords = "Adverse events, Chronic pain, Gastrointestinal, Nausea, Opioids, Vomiting",
author = "Frank Porreca and Ossipov, {Michael H.}",
year = "2009",
doi = "10.1111/j.1526-4637.2009.00583.x",
language = "English (US)",
volume = "10",
pages = "654--662",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain

T2 - Mechanisms, implications, and management options

AU - Porreca, Frank

AU - Ossipov, Michael H.

PY - 2009

Y1 - 2009

N2 - Objectives. Gastrointestinal (GI) side effects such as nausea and vomiting are common following opioid analgesia and represent a significant cause of patient discomfort and treatment dissatisfaction. This review examines the mechanisms that produce these side effects, their impact on treatment outcomes in chronic pain patients, and counteractive strategies. Results. A number of mechanisms by which opioids produce nausea and vomiting have been identified. These involve both central and peripheral sites including the vomiting center, chemoreceptor trigger zones, cerebral cortex, and the vestibular apparatus of the brain, as well as the GI tract itself. Nausea and vomiting have a negative impact on treatment efficacy and successful patient management because they limit the effective analgesic dosage that can be achieved and are frequently reported as the reason for discontinuation of opioid pain medication or missed doses. While various strategies such as antiemetic agents or opioid switching can be employed to control these side effects, neither option is ideal because they are not always effective and incur additional costs and inconvenience. Opioid-sparing analgesic agents may provide a further alternative to avoid nausea and vomiting due to their reduced reliance on mu-opioid signalling pathways to induce analgesia. Conclusions. Nausea and vomiting side effects limit the analgesic efficiency of current opioid therapies. There is a clear need for the development of improved opioid-based analgesics that mitigate these intolerable effects.

AB - Objectives. Gastrointestinal (GI) side effects such as nausea and vomiting are common following opioid analgesia and represent a significant cause of patient discomfort and treatment dissatisfaction. This review examines the mechanisms that produce these side effects, their impact on treatment outcomes in chronic pain patients, and counteractive strategies. Results. A number of mechanisms by which opioids produce nausea and vomiting have been identified. These involve both central and peripheral sites including the vomiting center, chemoreceptor trigger zones, cerebral cortex, and the vestibular apparatus of the brain, as well as the GI tract itself. Nausea and vomiting have a negative impact on treatment efficacy and successful patient management because they limit the effective analgesic dosage that can be achieved and are frequently reported as the reason for discontinuation of opioid pain medication or missed doses. While various strategies such as antiemetic agents or opioid switching can be employed to control these side effects, neither option is ideal because they are not always effective and incur additional costs and inconvenience. Opioid-sparing analgesic agents may provide a further alternative to avoid nausea and vomiting due to their reduced reliance on mu-opioid signalling pathways to induce analgesia. Conclusions. Nausea and vomiting side effects limit the analgesic efficiency of current opioid therapies. There is a clear need for the development of improved opioid-based analgesics that mitigate these intolerable effects.

KW - Adverse events

KW - Chronic pain

KW - Gastrointestinal

KW - Nausea

KW - Opioids

KW - Vomiting

UR - http://www.scopus.com/inward/record.url?scp=67049162816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049162816&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4637.2009.00583.x

DO - 10.1111/j.1526-4637.2009.00583.x

M3 - Article

C2 - 19302436

AN - SCOPUS:67049162816

VL - 10

SP - 654

EP - 662

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 4

ER -